These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32655889)

  • 1. Open versus arthroscopic surgery for diffuse tenosynovial giant-cell tumours of the knee: a systematic review.
    Quaresma MB; Portela J; Soares do Brito J
    EFORT Open Rev; 2020 Jun; 5(6):339-346. PubMed ID: 32655889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).
    Lingamfelter M; Novaczyk ZB; Cheng EY
    JBJS Essent Surg Tech; 2022; 12(2):. PubMed ID: 36741035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
    Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
    Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
    Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
    Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional outcome and quality of life after the surgical treatment for diffuse-type giant-cell tumour around the knee: a retrospective analysis of 30 patients.
    van der Heijden L; Mastboom MJ; Dijkstra PD; van de Sande MA
    Bone Joint J; 2014 Aug; 96-B(8):1111-8. PubMed ID: 25086129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midterm outcomes of 18 patients with primary intra-articular diffuse tenosynovial giant cell tumor (TGCT) of the knee treated with complete arthroscopic synovectomy and postoperative low-dose radiotherapy at a mean follow-up of 68 months.
    Tie K; Wang H; Chen B; Yang X; Chen L
    Arch Orthop Trauma Surg; 2023 Apr; 143(4):2121-2127. PubMed ID: 35562595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arthroscopic Versus Open Management of Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: A Meta-analysis of Retrospective Cohort Studies.
    Chandra AA; Agarwal S; Donahue A; Handorf E; Abraham JA
    J Am Acad Orthop Surg Glob Res Rev; 2021 Dec; 4(12):. PubMed ID: 34882586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell tumor of tendon sheath: Open surgery or arthroscopic synovectomy? A systematic review of the literature.
    Noailles T; Brulefert K; Briand S; Longis PM; Andrieu K; Chalopin A; Gouin F
    Orthop Traumatol Surg Res; 2017 Sep; 103(5):809-814. PubMed ID: 28428036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pigmented villonodular synovitis of the knee.
    Aurégan JC; Klouche S; Bohu Y; Lefèvre N; Herman S; Hardy P
    Arthroscopy; 2014 Oct; 30(10):1327-41. PubMed ID: 24999007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of tenosynovial giant cell tumour of the foot and ankle.
    Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
    Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigmented villonodular synovitis of the knee: A retrospective analysis of 214 cases at a UK tertiary referral centre.
    Patel KH; Gikas PD; Pollock RC; Carrington RW; Cannon SR; Skinner JA; Briggs TW; Aston WJS
    Knee; 2017 Aug; 24(4):808-815. PubMed ID: 28442184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Advanced Tenosynovial Giant Cell Tumor of the Knee Diagnosed During Total Knee Arthroplasty.
    Lei P; Sun R; Liu H; Zhu J; Wen T; Hu Y
    J Arthroplasty; 2017 Jun; 32(6):1850-1855. PubMed ID: 28161138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of arthroscopic excision based on the distribution of the tenosynovial giant cell tumor around knee joint.
    Yoo HJ; Nam HS; Park SB; Lee YS
    Knee; 2023 Mar; 41():360-372. PubMed ID: 36848705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI of diffuse-type tenosynovial giant cell tumour in the knee: a guide for diagnosis and treatment response assessment.
    Spierenburg G; Suevos Ballesteros C; Stoel BC; Navas Cañete A; Gelderblom H; van de Sande MAJ; van Langevelde K
    Insights Imaging; 2023 Feb; 14(1):22. PubMed ID: 36725759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-guided, intensity-modulated radiotherapy for the treatment of diffuse-type tenosynovial giant cell tumor of the knee: Case report and review of the literature.
    Xiang X; Jiang W; Qiu C; Xiao N; Liang J
    Medicine (Baltimore); 2021 Jul; 100(28):e26659. PubMed ID: 34260572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: Open versus arthroscopic synovectomy for pigmented villonodular synovitis of the knee.
    Rodriguez-Merchan EC
    J Orthop Surg (Hong Kong); 2014 Dec; 22(3):406-8. PubMed ID: 25550027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
    Verspoor FGM; Mastboom MJL; Hannink G; van der Graaf WTA; van de Sande MAJ; Schreuder HWB
    Bone Joint J; 2019 Mar; 101-B(3):272-280. PubMed ID: 30813787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis.
    Mollon B; Lee A; Busse JW; Griffin AM; Ferguson PC; Wunder JS; Theodoropoulos J
    Bone Joint J; 2015 Apr; 97-B(4):550-7. PubMed ID: 25820897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).
    van der Heijden L; Gibbons CL; Dijkstra PD; Kroep JR; van Rijswijk CS; Nout RA; Bradley KM; Athanasou NA; Hogendoorn PC; van de Sande MA
    J Bone Joint Surg Br; 2012 Jul; 94(7):882-8. PubMed ID: 22733940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
    Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
    Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.